ocalivahcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://ocalivahcp.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | Primary Biliary Cholangitis Treatment – OCALIVA® (obeticholic acid) | Official US HCP |
| Description | For when UDCA alone isn’t OCALIVA is a primary biliary cholangitis (PBC) treatment used with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or alone in adults unable to tolerate UDCA. See Full Prescribing Information and Boxed Warning. Also see |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 161.47.95.117 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
ocalivahcp.com Valuation
|
US$5,270,784
Last updated: 2023-05-12 00:24:18
ocalivahcp.com has Semrush global rank of 2,008,108. ocalivahcp.com has an estimated worth of US$ 5,270,784, based on its estimated Ads revenue. ocalivahcp.com receives approximately 608,168 unique visitors each day. Its web server is located in United States, with IP address 161.47.95.117. According to SiteAdvisor, ocalivahcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,270,784 |
| Daily Ads Revenue | US$4,866 |
| Monthly Ads Revenue | US$145,961 |
| Yearly Ads Revenue | US$1,751,522 |
| Daily Unique Visitors | 40,545 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| ocalivahcp.com. | A | 14400 | IP: 161.47.95.117 |
| ocalivahcp.com. | NS | 14400 | NS Record: dns101.register.com. |
| ocalivahcp.com. | NS | 14400 | NS Record: dns102.register.com. |
| ocalivahcp.com. | MX | 14400 | MX Record: 10 mx.mailanyone.net. |
| ocalivahcp.com. | TXT | 14400 | TXT Record: iu9fa5jd3vkr9tk8gfog93rn5u |
| ocalivahcp.com. | TXT | 14400 | TXT Record: v=spf1 include:mailanyone.net include:protomail.com include:electric.net ~all |
HtmlToTextCheckTime:2023-05-12 00:24:18
| This site is intended for US healthcare professionals only Resources and Patient Profiles Frequently Asked Questions Safety Information Register for Updates Prescribing Information Patient Site Important Safety Information Prescribing information Disease State Mechanism of Action Efficacy 5-Year Open-Label Extension Data Safety Dosing Access Resources and Patient Profiles Frequently Asked Questions Safety Information Register for Updates Prescribing Information Patient Site Speak live with your Intercept Territory Business Manager CONNECT NOW SCHEDULE A MEETING Speak live with your TBM --> For when UDCA alone isn’t Enough. OCALIVA activates the FXR 1 to take UDCA treatment to the next level. It can also be used as monotherapy for patients who cannot tolerate UDCA. 1 SEE EFFICACY DATA FXR, farnesoid X receptor; PBC, primary biliary cholangitis; UDCA, ursodeoxycholic acid. OCALIVA at-a-glance OCALIVA, an FXR agonist, is effective in combination with UDCA for the treatment of PBC in |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx Date: Sun, 21 Nov 2021 08:47:22 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://ocalivahcp.com/ |
ocalivahcp.com Whois Information
Domain Name: OCALIVAHCP.COM Registry Domain ID: 2005843468_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.register.com Registrar URL: http://www.register.com Updated Date: 2021-11-18T19:52:44Z Creation Date: 2016-02-23T20:49:16Z Registry Expiry Date: 2022-02-23T20:49:16Z Registrar: Register.com, Inc. Registrar IANA ID: 9 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: pendingTransfer https://icann.org/epp#pendingTransfer Name Server: DNS101.REGISTER.COM Name Server: DNS102.REGISTER.COM DNSSEC: unsigned >>> Last update of whois database: 2021-11-21T08:40:00Z <<< |